Table II.
Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
Variables | HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age (years) | <55 vs. ≥55 | 1.409 | 0.658–3.017 | 0.378 | NA | ||
Sex | Male vs. female | 0.575 | 0.274–1.206 | 0.143 | NA | ||
Lymph nodes metastasis | No vs. yes | 0.296 | 0.129–0.680 | 0.004a | 0.253 | 0.088–0.728 | 0.011a |
Distant metastasis | No vs. yes | 2.707 | 1.296–5.657 | 0.008a | 2.616 | 1.034–6.619 | 0.04 a |
Breslow's depth (mm) | ≤5 vs. >5 | 2.105 | 0.979–4.529 | 0.057 | NA | ||
Clinical stage | I–II vs. III–IV | 0.234 | 0.099–0.551 | 0.001a | 1.239 | 0.365–4.200 | 0.731 |
UHRF1 | Low vs. high | 3.889 | 1.718–8.801 | 0.001a | 3.520 | 1.312–9.442 | 0.012a |
Ki-67 | Low vs. high | 3.023 | 1.378–6.631 | 0.006a | 1.239 | 0.754–4.157 | 0.189 |
Univatiate and multivariate analysis, Cox proportional hazard regression model. OS, overall survival time; HR, hazard ratio; CI, confidence interval; NA, not applicable.
Statistically significant.